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Abstract 
The Gene Ontology is being normalized and extended 
to include computable logical definitions. These 
definitions are partitioned into mutually exclusive 
cross-product sets, many of which reference other 
OBO Foundry ontologies. The results can be used to 
reason over the ontology, and to make cross-ontology 
queries. 
 
Introduction 
The Gene Ontology (GO)1 was conceived of as a 
means of providing structured annotations for genes 
and gene products, in terms of molecular function 
(MF), biological process (BP) and cellular 
component (CC). The current version of the GO has 
nearly 27,000 terms and 47,000 relationships. As the 
GO evolves, the relational graph becomes more 
tangled, which poses a problem for ontology 
maintenance, correctness and visualization. It has 
long been recognized that a normalized approach to 
ontology development helps with re-use, 
maintainability and evolution2,3,4. The OBO Foundry5 
was initiated  in part to provide a means of 
normalizing the GO, such that for example the GO 
definition of “oocyte differentiation” could reference 
the term “oocyte” in the OBO Cell ontology (CL), 
and an automated reasoner tool could be used to 
classify this as a kind of “germ cell differentiation”, 
based on the CL classification. This is also an 
example of a ‘re-use’ pattern, common in software 
engineering. 
Almost all of the terms in the GO have textual 
definitions, crafted for the human users of the GO. 
When these textual definitions are rendered in a 
computable from, we can leverage reasoner 
technology to automate the more tedious and error-
prone aspects of ontology maintenance. We can also 
use these computable definitions to make cross-
ontology queries and better visualize the ontology. 
 
Logical Definitions and Cross Products 
We provide computable logical definitions for terms 
using genus-differentia constructs, of the form “an X 
is a G that D”. Here X is the term we are defining, G 
is the genus (more general term), and D is the 
differentia, a collection of characteristics that serve to 
discriminate instances of X from other instances of 
G. The differentiae are specified as relationships to 
other terms, using relations from the Relations 
Ontology6. In OBO Format (the native means of 
representing the GO) these are specified using 
intersection_of tags, which list the necessary 
and sufficient conditions for a term. For example: 
 
[Term] 
id: GO:0032543 
name: mitochondrial translation 
intersection_of: GO:0006412 ! translation 
intersection_of: occurs_in GO:0005739 ! 
mitochondrion 
 
In OWL Manchester Syntax, this is written as an 
equivalence axiom between the class mitochondrial 
translation and the description translation and 
occurs_in some mitochondrion. 
 
In the example above, the logical definition for the 
process references a GO cellular component term. 
Often we will want to reference other OBO 
ontologies, and this introduces multiple 
dependencies. We therefore partition the full set of 
logical definitions for GO into cross-product 
mapping. A cross-product of two ontologies A x B is 
the set of biologically meaningful terms that can be 
constructed by extending A using terms from B as 
differentia. The GO term in the example above would 
be mapped to a definition in the BP x CC cross 
product. 
 
Each cross-product mapping is maintained as an 
individual resource, independent of the others (see 
Table 1). Currently they are optional add-ons to the 
GO. We distinguish between intra-GO cross products 
and inter-GO cross products, the latter consisting of 
logical definitions that reference an OBO ontology 
not under the management of the Gene Ontology 
Consortium.  
A subset of the intra-GO cross products are the self-
cross products: terms that can be defined solely by 
using terms in the same ontology. 
 
  
Biological processes 
The BP x CC cross-product set includes definitions 
for biological process terms that have  cellular 
component terms as differentia. Sometimes we need 
to specify the subcellular location in which a process 
occurs, in which case we use an occurs_in relation. 
Sometimes we are describing the output of a process, 
such as when a cellular component is assembled or 
disassembled. The GO also has a rich set of 
subcellular transport terms, in which case the logical 
definition needs to be precise about the origin, 
destination and route of the transported entity. 
 
Many BP terms can be defined using a BP term in the 
differentia. For example, the different phases of the 
cell cycle can be subtyped according to whether they 
are part of mitosis or meiosis. These definitions are 
grouped into the BP x BP set. 
 
GO includes 3 broad categories of regulatory 
processes – regulation of molecular function, 
regulation of biological process, and regulation of 
biological quality – these comprise 3 distinct cross-
product sets. The first two are intra-GO; the latter 
references terms from the PATO ontology of 
biological qualities7, together with anatomical 
ontologies. 
The cross products make use of 3 new relations 
introduced into GO – regulates, negatively_regulates 
and positively_regulates. 
We have created a separate cross-product set  for the 
more complex multi-organism interaction regulation 
terms. The logical definitions we provide here are 
necessarily a simplification, as we must go beyond 
the current expressive capabilities of OBO or OWL 
in order to represent inter-organism interactions. 
 
Anatomy 
GO has many terms describing development at the 
cellular and gross anatomical level. There are also 
non-development terms that nevertheless reference 
types of anatomical entity – for example, “muscle 
contraction”. 
We use the species-neutral OBO Cell ontology (CL) 8 
for defining terms such as “oocyte differentiation” in 
the BP x CL set. Gross anatomy proves more of a 
challenge because the main OBO gross anatomy 
ontologies are specific to a species or taxon. We 
therefore extracted the implicit anatomical ontology 
embedded in the GO and used this together with 
alignments to existing anatomy ontologies to seed a 
multi-species anatomy ontology called Uberon, 
which is used in the definition of terms such as 
“muscle contraction”. These definitions are part of 
the BP x Uberon set. Uberon covers only animals; 
plant development terms are in BP x PO (plant 
anatomy ontology). There are also individual species-
species extensions such as BP x Fly_anatomy. 
 
Molecules and proteins 
Molecular and chemical entities are represented in 
the CHEBI ontology9, with proteins represented in 
PRO10. We use these in 3 cross-product sets, 
{BP,MF} x CHEBI11 and BP x PRO. The Protein 
Ontology is still relatively new, so this last set is 
currently relatively small. We also intend to work 
with the PRO curators to make an CC x PRO set.  
 
Cellular components 
Many of the terms in CC can be assigned logical 
definitions based on parthood relations to other 
components – for example, “nuclear chromosome” is 
a chromosome that is part_of a nucleus. For other 
definitions in CC x CC, we introduce additional 
spatial relations, such as surrounds and surrounded 
by. 
 
The GO CC ontology has many terms representing 
complexes, some of which are defined by their 
constituent parts, others by function. The latter have 
logical definitions in the CC x MF cross-product.  
 
Some cell component terms are differentiated by the 
cell type of which they are a part – for example, a 
sarcoplasm is a cytoplasm that is part_of  a muscle 
cell. We map GO terms such as sarcoplasm to the BP 
x CL set, most of which use the part_of relation. For 
others, such as neuromuscular junction we use 
adjacency relations. 
 
Reasoning 
The current set of logical definitions can be used by a 
variety of different reasoners. We use the OBO-Edit12 
reasoner, because it is integrated within the normal 
editing environment for the GO, and provides 
incremental reasoning support. 
We have not found any reasoner that is capable of 
reasoning over the union of the GO plus all cross-
product sets plus all referenced ontologies. However, 
we are able to reason over individual cross-product 
sets and their referenced ontologies individually. 
 
We use reasoning primarily for ontology 
maintenance, to compute and check the subsumption 
hierarchy. The GO regulation hierarchy in particular 
has benefited from this work, with over 2000 missing 
links added to GO, which could potentially improve 
the results of term enrichment analyses. We use the 
reasoner in what we call ‘repair mode’ – we invoke 
the reasoner to spot mistakes and fill in missing links 
in the ontology, always asserting links that can be 
automatically computed. This ensures that editors can 
  
edit the ontology without invoking the reasoner over 
the union of all logical definitions. This stands in 
contrast to how the reasoner is used in SO and the Fly 
anatomy ontology. We also use the reasoner to make 
inferences about the source ontologies13. 
 
We are still exploring uses of the cross-product sets 
beyond ontology construction and maintenance. This 
includes improved visualization, enhancing term 
enrichment analyses, annotation inferences and using 
the CHEBI cross-products to harmonize pathway 
database representations and GO metabolic 
processes. 
 
Post-composition 
The GO does not pre-compose terms for all 
biologically meaningful compositions of terms, as 
this would lead to a large, unwieldy ontology. The 
guiding principle is to generate compositional terms 
where the differentia is important to the biology. We 
are simultaneously exploring an approach whereby 
annotators can extend GO terms on-the-fly, i.e. 
selecting compositions from the cross-product at 
annotation time. For example, an annotator can select 
the GO term ‘mitochondrial membrane’ for a cellular 
component annotation and extend this using a 
differentia ‘part_of Purkinje cell’, with the differentia 
term coming from CL. This is logically equivalent to 
annotating to a term ‘mitochondrial membrane of 
Purkinje cell’, but avoids bloating the ontology with 
the full set of biologically instantiable terms in the 
CC x CL cross-product. 
 
 
 
 
 
 XP Name Size Examples 
 * Biological process 606 S phase of mitotic cell cycle = S phase  and part_of mitosis 
Biological process X self (regulates) 3529 Regulation of neuroblast proliferation = biological regulation and 
regulates neuroblast proliferation 
Biological process X self (multi-organism) 374 modulation of intracellular transport in other organism during 
symbiotic interaction = interspecies interaction between organisms 
and regulates intracellular transport and during symbiosis and 
regulates_process_in external organism 
re
gu
la
tio
n 
Biological process X MF (regulates) 201 Regulation of protein kinase activity = biological regulation and 
regulates protein kinase activity 
Biological process X cellular component 476 Mitochondrial translation = translation and occurs_in mitochondrion 
Biological process X SO 
  
61 
  
group I intron catabolic process = catabolic process and has_input 
group I intron  
* Cellular component X self 682 Acrosomal membrane = membrane and surrounds acrosome 
Cellular component X molecular function 173 histone deacetylase complex = protein complex and has_function 
histone deacetylase activity 
* Molecular function X self (regulates) 104 Lipase activator activity = molecular function and regulates lipase 
activity 
In
tra
-G
O
 
Molecular function X cellular component 48 Microtubule motor activity = motor activity and 
results_in_movement_along microtubule  
Biological process X cell 544 Oocyte differentiation = cell differentiation and 
results_in_acquisition_of_features_of oocyte 
Biological process X Uberon 583 Neural plate formation = anatomical structure formation and 
results_in_formation_of neural plate 
Biological process X quality {X anatomy} 31 Regulation of cell volume = biological regulation and regulates (volume 
and quality_of cell) 
Molecular function X Uberon 9 Structural constituent of bone = structural molecule activity and 
inheres_in bone 
A
na
to
m
y 
Cellular component X cell  28 Neuromuscular junction = synpase and adjacent_to motor neuron axon 
and adjacent_to contractile fiber  
Biological process X CHEBI 3077 L-cysteine catabolic process to taurine = catabolic process and 
has_input L-cysteine and has_output taurine 
 
CHEBI 
Molecular function X CHEBI 315 nitrate reductase activity = oxidoreductase activity and reduces nitrate 
In
te
r-
G
O
  
M
ol
ec
ul
e 
 
PRO Biological process X PRO 37 Interleukin-1 biosynthesis = biosynthetic process and has_output 
interleukin-1 
Table 1. GO logical definitions are partitioned into mutually exclusive cross-product sets. Examples are shown 
from each of the sets. The second column shows the number of existing GO terms that have been mapped to a 
logical definition in each set. Asterisks (*) denote self cross-products. In total 10878 terms have been mapped, 41% 
of all terms in the ontology. 
 
  
 
 
Conclusions 
The extended collection of cross-product resources described here represents a significant advance in the evolution 
of the GO and its integration with other OBO ontologies. The use of these logical definitions, in conjunction with a 
reasoner has substantially increased the quality of the GO and eased the more prosaic aspects of ontology 
maintenance. We are still exploring application beyond the ontology itself. 
 
This work also highlights the importance and necessity of the OBO Foundry effort, particularly with respect to 
efforts to create single orthogonal well-partitioned ontologies each representing a distinct domain of biology.  
 
Methods and availability 
 
In contrast to some ontology development efforts, in which computable definitions are assigned when terms are 
created, we have been working retrospectively, constructing logical descriptions for pre-existing terms. To help us 
with this task we use Obol14, which heuristically generates proposed logical definitions based using ontology-
specific grammars. Ontology editors then vet the definitions, often substantially. 
The full extended GO can be obtained on the GO wiki: 
http://wiki.geneontology.org/index.php/Category:Cross_Products 
Comments and contributions are welcome. 
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